Kaneka Corporation is a company operating in the pharmaceutical industry.
By applying its unique combination of bio-transformations and organic synthesis, Kaneka is manufacturing advanced intermediates for 40 years for the pharmaceutical industry. Kaneka is a research driven manufacturer supplying valuable chiral synthons produced by innovative and cost-effective processes. Kaneka’s intensive R&D activities make it possible to support its customers worldwide from laboratory over pilot to full GMP manufacturing scale.Kaneka is the pioneer in natural CoQ10 (Ubidecarenone) and is the only manufacturer offering also the biologically-active form (Ubiquinol).
Company type
Products and services
Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Kaneka Corporation, 5, Rue Bois Saint-Jean, Seraing, Belgium, 4102
